The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy
Abstract
This study aims to individualize the selection of drugs for neuropathic pain by examining the potential coupling of a given drug's mechanism of action with the patient's pain modulation pattern. The latter is assessed by the conditioned pain modulation (CPM) and temporal summation (TS) protocols. We hypothesized that patients with a malfunctioning pain modulation pattern, such as less efficient CPM, would benefit more from drugs augmenting descending inhibitory pain control than would patients with a normal modulation pattern of efficient CPM. Thirty patients with painful diabetic neuropathy received 1 week of placebo, 1 week of 30 mg/d duloxetine, and 4 weeks of 60 mg/d duloxetine. Pain modulation was assessed psychophysically, both before and at the end of treatment. Patient assessment of drug efficacy, assessed weekly, was the study's primary outcome. Baseline CPM was found to be correlated with duloxetine efficacy (r=0.628, P<.001, efficient CPM is marked negative), such that less efficient CPM predicted efficacious use of duloxetine. Regression analysis (R(2)=0.673; P=.012) showed that drug efficacy was predicted only by CPM (P=.001) and not by pretreatment pain levels, neuropathy severity, depression level, or patient assessment of improvement by placebo. Furthermore, beyond its predictive value, the treatment-induced improvement in CPM was correlated with drug efficacy (r=-0.411, P=.033). However, this improvement occurred only in patients with less efficient CPM (16.8±16.0 to -1.1±15.5, P<.050). No predictive role was found for TS. In conclusion, the coupling of CPM and duloxetine efficacy highlights the importance of pain pathophysiology in the clinical decision-making process. This evaluative approach promotes personalized pain therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Screening Depressed Patients in Family Practice: A Rapid Technic
Beck, A. T., & Beck, R. W. (1972) · Postgraduate Medicine · doi:10.1080/00325481.1972.11713319 · Cited by 1,823
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
Baron, R., Binder, A., & Wasner, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70143-5 · Cited by 1,816
Dworkin, R. H., O'Connor, A. B., Audette, J., Baron, R., Gourlay, G. K., Haanpää, M. L., Kent, J. L., Krane, E. J., LeBel, A. A., Levy, R. M., et al. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0649 · Cited by 1,325
NeuPSIG guidelines on neuropathic pain assessment
Haanpää, M., Attal, N., Backonja, M., Baron, R., Bennett, M., Bouhassira, D., Cruccu, G., Hansson, P., Haythornthwaite, J. A., Iannetti, G. D., et al. (2011) · Pain · doi:10.1016/j.pain.2010.07.031 · Cited by 1,060
Prediction of chronic post-operative pain: Pre-operative DNIC testing identifies patients at risk
Yarnitsky, D., Crispel, Y., Eisenberg, E., Granovsky, Y., Ben-Nun, A., Sprecher, E., Best, L.-A., & Granot, M. (2008) · Pain · doi:10.1016/j.pain.2007.10.033 · Cited by 750
Self-citationYarnitsky, D. (2010) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32833c348b · Cited by 745
Self-citationWidespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition
Julien, N., Goffaux, P., Arsenault, P., & Marchand, S. (2005) · Pain · doi:10.1016/j.pain.2004.12.032 · Cited by 634
Bril, V., England, J., Franklin, G. M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D. J., Perkins, B., Russell, J. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166ebe · Cited by 634
Possible Deficiencies of Pain Modulation in Fibromyalgia
Lautenbacher, S., & Rollman, G. B. (1997) · The Clinical Journal of Pain · doi:10.1097/00002508-199709000-00003 · Cited by 545
Cited by
Colloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A. H., Yarnitsky, D., Freeman, R., Truini, A., Attal, N., Finnerup, N. B., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.2 · Cited by 2,058
Self-citationFeldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0092-1 · Cited by 1,697
New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
Feldman, E. L., Nave, K.-A., Jensen, T. S., & Bennett, D. L. H. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.005 · Cited by 915
Assessment and manifestation of central sensitisation across different chronic pain conditions
Arendt‐Nielsen, L., Morlion, B., Perrot, S., Dahan, A., Dickenson, A., Kress, H. G., Wells, C., Bouhassira, D., & Drewes, A. M. (2018) · European Journal of Pain · doi:10.1002/ejp.1140 · Cited by 695
Neurobiology of fibromyalgia and chronic widespread pain
Sluka, K. A., & Clauw, D. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.006 · Cited by 671
Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles
Baron, R., Maier, C., Attal, N., Binder, A., Bouhassira, D., Cruccu, G., Finnerup, N. B., Haanpää, M., Hansson, P., Hüllemann, P., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000000753 · Cited by 611
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus
Backonja, M. “., Attal, N., Baron, R., Bouhassira, D., Drangholt, M., Dyck, P. J., Edwards, R. R., Freeman, R., Gracely, R., Haanpaa, M. H., et al. (2013) · Pain · doi:10.1016/j.pain.2013.05.047 · Cited by 574
Self-citationPathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
Häuser, W., Ablin, J., Fitzcharles, M.-A., Littlejohn, G., Luciano, J. V., Usui, C., & Walitt, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.22 · Cited by 505
Unraveling the mechanisms of manual therapy: modeling an approach
Bialosky, J. E., Beneciuk, J. M., Bishop, M. D., Coronado, R. A., Penza, C. W., Simon, C. B., & George, S. Z. (2018) · Journal of Orthopaedic & Sports Physical Therapy · doi:10.2519/jospt.2018.7476 · Cited by 482
Davis, K. D., Aghaeepour, N., Ahn, A. H., Angst, M. S., Borsook, D., Brenton, A., Burczynski, M. E., Crean, C., Edwards, R., Gaudilliere, B., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0362-2 · Cited by 496
Reliability of conditioned pain modulation: a systematic review
Kennedy, D. L., Kemp, H. I., Ridout, D., Yarnitsky, D., & Rice, A. S. C. (2016) · Pain · doi:10.1097/j.pain.0000000000000689 · Cited by 456
Self-citationPatient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
Edwards, R. R., Dworkin, R. H., Turk, D. C., Angst, M. S., Dionne, R., Freeman, R., Hansson, P., Haroutounian, S., Arendt-Nielsen, L., Attal, N., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000602 · Cited by 403
Self-citationThe neurobiology of central sensitization
Harte, S. E., Harris, R. E., & Clauw, D. J. (2018) · Journal of Applied Biobehavioral Research · doi:10.1111/jabr.12137 · Cited by 394
Pain vulnerability: a neurobiological perspective
Denk, F., McMahon, S. B., & Tracey, I. (2014) · Nature Neuroscience · doi:10.1038/nn.3628 · Cited by 363
Role of endogenous pain modulation in chronic pain mechanisms and treatment
Yarnitsky, D. (2015) · Pain · doi:10.1097/01.j.pain.0000460343.46847.58 · Cited by 346
Self-citationChallenges of neuropathic pain: focus on diabetic neuropathy
Rosenberger, D. C., Blechschmidt, V., Timmerman, H., Wolff, A., & Treede, R.-D. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02145-7 · Cited by 325
Nir, R.-R., & Yarnitsky, D. (2015) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0000000000000126 · Cited by 314
Self-citationCan Quantitative Sensory Testing Move Us Closer to Mechanism-Based Pain Management?
Cruz-Almeida, Y., & Fillingim, R. B. (2014) · Pain Medicine · doi:10.1111/pme.12230 · Cited by 302
Neuropathic Pain: Mechanism-Based Therapeutics
Bannister, K., Sachau, J., Baron, R., & Dickenson, A. H. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021524 · Cited by 302
Pain modulation profile and pain therapy: Between pro- and antinociception
Yarnitsky, D., Granot, M., & Granovsky, Y. (2014) · Pain · doi:10.1016/j.pain.2013.11.005 · Cited by 297
Self-citationPeripheral input and its importance for central sensitization
Baron, R., Hans, G., & Dickenson, A. H. (2013) · Annals of Neurology · doi:10.1002/ana.24017 · Cited by 280
Mechanisms of the gabapentinoids and α2δ‐1 calcium channel subunit in neuropathic pain
Patel, R., & Dickenson, A. H. (2016) · Pharmacology Research & Perspectives · doi:10.1002/prp2.205 · Cited by 277
Petersen, K. K., Arendt-Nielsen, L., Simonsen, O., Wilder-Smith, O., & Laursen, M. B. (2015) · Pain · doi:10.1016/j.pain.0000000000000022 · Cited by 269
Baron, R., Förster, M., & Binder, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70189-8 · Cited by 262
Petersen, K. K., Vaegter, H. B., Stubhaug, A., Wolff, A., Scammell, B. E., Arendt-Nielsen, L., & Larsen, D. B. (2021) · Pain · doi:10.1097/j.pain.0000000000002019 · Cited by 140
Psychology of Chronic Pelvic Pain: Prevalence, Neurobiological Vulnerabilities, and Treatment
TILL, S. R., AS-SANIE, S., & SCHREPF, A. (2019) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000412 · Cited by 134
Bouhassira, D., Wilhelm, S., Schacht, A., Perrot, S., Kosek, E., Cruccu, G., Freynhagen, R., Tesfaye, S., Lledó, A., Choy, E., et al. (2014) · Pain · doi:10.1016/j.pain.2014.08.020 · Cited by 132
Imai, Y., Petersen, K. K., Mørch, C. D., & Arendt Nielsen, L. (2016) · Somatosensory & Motor Research · doi:10.1080/08990220.2016.1229178 · Cited by 127
Central sensitization in humans: assessment and pharmacology
Arendt-Nielsen, L. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-46450-2_5 · Cited by 125
“…α(2)-adrenoceptor agonist) (Baba et al. 2012), buprenorphine (Arendt-Nielsen et al. 2012a, b), fentanyl (Arendt-Nielsen et al. 2012a, b), duloxetine (Yarnitsky et al. 2012), and apomorphine (a non-specific dopamine agonist) (Treister et al. 2013), whereas oxycodone seems not to modulate CPM (Suzan…”
BackgroundMethodResting state connectivity correlates with drug and placebo response in fibromyalgia patients
Schmidt-Wilcke, T., Ichesco, E., Hampson, J. P., Kairys, A., Peltier, S., Harte, S., Clauw, D. J., & Harris, R. E. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2014.09.007 · Cited by 122
Meretoja, T. J., Andersen, K. G., Bruce, J., Haasio, L., Sipilä, R., Scott, N. W., Ripatti, S., Kehlet, H., & Kalso, E. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.3413 · Cited by 106
Acute and Chronic Pain Processing in the Thalamocortical System of Humans and Animal Models
Groh, A., Krieger, P., Mease, R. A., & Henderson, L. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2017.09.042 · Cited by 101
Prevention and Treatment of Chronic Postsurgical Pain: A Narrative Review
Steyaert, A., & Lavand’homme, P. (2018) · Drugs · doi:10.1007/s40265-018-0866-x · Cited by 97
Gerhardt, A., Eich, W., Janke, S., Leisner, S., Treede, R.-D., & Tesarz, J. (2016) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000000300 · Cited by 91
Bäckryd, E., Persson, E. B., Larsson, A. I., Fischer, M. R., & Gerdle, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192623 · Cited by 75
Petersen, K. K.-S. (2023) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2022-0082 · Cited by 22
Metadata
- Authors
- Yarnitsky, D., Granot, M., Nahman-Averbuch, H., Khamaisi, M., & Granovsky, Y.
- Venue
- Pain
- Published
- 2012-06
- Volume
- 153
- Issue
- 6
- Pages
- 1193-1198
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2028204969
- Cited by
- 561
- References
- 31
- FWCI
- 22.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.